OncoHost to Present New Research on Plasma Proteomics-Based Treatment Selection in Melanoma at ESMO 2025

BINYAMINA, Israel and CARY, N.C., Oct. 15, 2025 /PRNewswire/ -- OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, today announced that its latest research has been accepted for poster presentation at the European Society for...